Percutaneous Leads

This device is approved for use in the United States and select international markets.

Percutaneous Lead

Built on clinical research and an ongoing assessment of physician, clinician, and patient needs, our Octrode™, Quattrode™, and Axxess™ leads meet a variety of clinical requirements and offer exceptional control for ease of insertion and placement. The leads’ low impedance design contributes to system longevity, and their optimal electrode size and spacing provide the right balance of coverage and specificity.1,2

Key Features

  • Can be configured as a single, dual, or tripolar array
  • Clinically proven electrode spacing to optimize specificity and coverage2

References

1. Alo KM. Lead positioning and programming strategies in the treatment of complex pain. Neuromodulation. 1999;2:165-170.
2. Alo KM,Yland MJ, Kramer DL, Charnov JH, Redko V. Computer assisted and patient interactive programming of dual octrode spinal cord stimulation in the treatment of chronic pain. Neuromodulation. 1998;1:30-45.